1. Home
  2. MREO vs VVR Comparison

MREO vs VVR Comparison

Compare MREO & VVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • VVR
  • Stock Information
  • Founded
  • MREO 2015
  • VVR 1998
  • Country
  • MREO United Kingdom
  • VVR United States
  • Employees
  • MREO N/A
  • VVR N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • VVR Trusts Except Educational Religious and Charitable
  • Sector
  • MREO Health Care
  • VVR Finance
  • Exchange
  • MREO Nasdaq
  • VVR Nasdaq
  • Market Cap
  • MREO 577.6M
  • VVR 603.8M
  • IPO Year
  • MREO N/A
  • VVR N/A
  • Fundamental
  • Price
  • MREO $3.68
  • VVR $3.88
  • Analyst Decision
  • MREO Strong Buy
  • VVR
  • Analyst Count
  • MREO 4
  • VVR 0
  • Target Price
  • MREO $7.50
  • VVR N/A
  • AVG Volume (30 Days)
  • MREO 769.7K
  • VVR 692.2K
  • Earning Date
  • MREO 11-12-2024
  • VVR 01-01-0001
  • Dividend Yield
  • MREO N/A
  • VVR 11.38%
  • EPS Growth
  • MREO N/A
  • VVR N/A
  • EPS
  • MREO N/A
  • VVR N/A
  • Revenue
  • MREO $1,000,000.00
  • VVR N/A
  • Revenue This Year
  • MREO $16.39
  • VVR N/A
  • Revenue Next Year
  • MREO $9.44
  • VVR N/A
  • P/E Ratio
  • MREO N/A
  • VVR N/A
  • Revenue Growth
  • MREO N/A
  • VVR N/A
  • 52 Week Low
  • MREO $1.86
  • VVR $3.55
  • 52 Week High
  • MREO $5.02
  • VVR $4.38
  • Technical
  • Relative Strength Index (RSI)
  • MREO 39.84
  • VVR 40.50
  • Support Level
  • MREO $3.18
  • VVR $3.86
  • Resistance Level
  • MREO $4.40
  • VVR $3.98
  • Average True Range (ATR)
  • MREO 0.24
  • VVR 0.04
  • MACD
  • MREO -0.06
  • VVR 0.00
  • Stochastic Oscillator
  • MREO 41.39
  • VVR 12.50

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About VVR Invesco Senior Income Trust (DE)

Invesco Senior Income Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide a high level of current income, consistent with the preservation of capital. The company invests in a portfolio of interests in floating or variable senior loans to corporations, partnerships, and other entities which operate in a variety of industries and geographic regions.

Share on Social Networks: